Latest Insider Transactions at Abiomed Inc (ABMD)
This section provides a real-time view of insider transactions for Abiomed Inc (ABMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ABIOMED INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ABIOMED INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.02%
|
-
|
|
Mar 31
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.08%
|
-
|
|
Feb 17
2021
|
Myron L Rolle |
BUY
Grant, award, or other acquisition
|
Direct |
790
+50.0%
|
-
|
|
Feb 17
2021
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
3,750
-2.08%
|
$1,177,500
$314.01 P/Share
|
|
Feb 16
2021
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
3,750
-2.04%
|
$1,237,500
$330.67 P/Share
|
|
Feb 01
2021
|
Dorothy E Puhy |
SELL
Open market or private sale
|
Direct |
5,000
-21.8%
|
$1,750,000
$350.51 P/Share
|
|
Jan 28
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-13.54%
|
$1,830,000
$366.0 P/Share
|
|
Jan 28
2021
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.92%
|
$330,000
$66.25 P/Share
|
|
Dec 29
2020
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-15.66%
|
$1,605,000
$321.0 P/Share
|
|
Dec 22
2020
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,682
-1.69%
|
$499,554
$297.13 P/Share
|
|
Dec 21
2020
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,474
-7.14%
|
$1,614,830
$295.91 P/Share
|
|
Nov 18
2020
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
750
-0.41%
|
$201,000
$268.34 P/Share
|
|
Nov 17
2020
|
Martin P Sutter |
SELL
Open market or private sale
|
Direct |
750
-0.4%
|
$201,750
$269.53 P/Share
|
|
Nov 06
2020
|
Marc A Began VP & GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-3.31%
|
$41,616
$272.4 P/Share
|
|
Sep 30
2020
|
Andrew J Greenfield VP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.11%
|
-
|
|
Sep 30
2020
|
Michael R Minogue CHAIRMAN, PRESIDENT, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.03%
|
-
|